Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Meridian Biopharmaceuticals GmbH
DescriptionHumanized mAb against tumor-associated antigen Lewis Y
Molecular Target Tumor-associated antigen GBU4-5 (GBU4-5)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today